These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36048131)

  • 1. Targeting glucose-6-phosphate dehydrogenase by 6-AN induces ROS-mediated autophagic cell death in breast cancer.
    Li Y; Zheng F; Zhang Y; Lin Z; Yang J; Han X; Feng Y; Pei X; Li F; Liu Q; Yan L; Li T; Zhang Y; Li D; Fu Z; Wang C; Sun Q; Li C
    FEBS J; 2023 Feb; 290(3):763-779. PubMed ID: 36048131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation.
    Mele L; la Noce M; Paino F; Regad T; Wagner S; Liccardo D; Papaccio G; Lombardi A; Caraglia M; Tirino V; Desiderio V; Papaccio F
    J Exp Clin Cancer Res; 2019 Apr; 38(1):160. PubMed ID: 30987650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
    Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
    J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIKE-A promotes glioblastoma growth by driving PPP flux through increasing G6PD expression mediated by phosphorylation of STAT3.
    Sun M; Sheng H; Wu T; Song J; Sun H; Wang Y; Wang J; Li Z; Zhao H; Tan J; Li Y; Chen G; Huang Q; Zhang Y; Lan B; Liu S; Shan C; Zhang S
    Biochem Pharmacol; 2021 Oct; 192():114736. PubMed ID: 34411567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the pentose phosphate pathway increases reactive oxygen species and induces apoptosis in thyroid cancer cells.
    Liu CL; Hsu YC; Lee JJ; Chen MJ; Lin CH; Huang SY; Cheng SP
    Mol Cell Endocrinol; 2020 Jan; 499():110595. PubMed ID: 31563469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS‑MAPK axis pathway.
    Zhang Q; Han Q; Yang Z; Ni Y; Agbana YL; Bai H; Yi Z; Yi X; Kuang Y; Zhu Y
    Int J Oncol; 2020 Jul; 57(1):197-212. PubMed ID: 32319593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells.
    Sun Y; Gu X; Zhang E; Park MA; Pereira AM; Wang S; Morrison T; Li C; Blenis J; Gerbaudo VH; Henske EP; Yu JJ
    Cell Death Dis; 2014 May; 5(5):e1231. PubMed ID: 24832603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation.
    Meng Q; Zhang Y; Sun H; Yang X; Hao S; Liu B; Zhou H; Wang Y; Xu ZX
    Redox Biol; 2024 May; 71():103108. PubMed ID: 38457903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis.
    Hong X; Song R; Song H; Zheng T; Wang J; Liang Y; Qi S; Lu Z; Song X; Jiang H; Liu L; Zhang Z
    Gut; 2014 Oct; 63(10):1635-47. PubMed ID: 24352616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro.
    Chen X; Xu Z; Zhu Z; Chen A; Fu G; Wang Y; Pan H; Jin B
    Int J Oncol; 2018 Oct; 53(4):1703-1712. PubMed ID: 30066842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired pentose phosphate pathway in the development of 3D MCF-7 cells mediated intracellular redox disturbance and multi-cellular resistance without drug induction.
    Wang W; Cai Q; Zhou F; Liu J; Jin X; Ni P; Lu M; Wang G; Zhang J
    Redox Biol; 2018 May; 15():253-265. PubMed ID: 29291545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NeuroD1 promotes tumor cell proliferation and tumorigenesis by directly activating the pentose phosphate pathway in colorectal carcinoma.
    Li Z; He Y; Li Y; Li J; Zhao H; Song G; Miyagishi M; Wu S; Kasim V
    Oncogene; 2021 Dec; 40(50):6736-6747. PubMed ID: 34657129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth.
    Rao X; Duan X; Mao W; Li X; Li Z; Li Q; Zheng Z; Xu H; Chen M; Wang PG; Wang Y; Shen B; Yi W
    Nat Commun; 2015 Sep; 6():8468. PubMed ID: 26399441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 promotes breast cancer cell migration via up-regulation of G6PD/HIF-1α/Notch1 axis.
    Zhang HS; Zhang ZG; Du GY; Sun HL; Liu HY; Zhou Z; Gou XM; Wu XH; Yu XY; Huang YH
    J Cell Mol Med; 2019 May; 23(5):3451-3463. PubMed ID: 30809937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth.
    Lu C; Yang D; Klement JD; Colson YL; Oberlies NH; Pearce CJ; Colby AH; Grinstaff MW; Liu Z; Shi H; Ding HF; Liu K
    Oncogene; 2022 Apr; 41(18):2651-2662. PubMed ID: 35351997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HuaChanSu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression.
    Wu Q; Ge XL; Geng ZK; Wu H; Yang JY; Cao SR; Yang AL
    Heliyon; 2024 Feb; 10(3):e25144. PubMed ID: 38322888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
    Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
    Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of G6PD activity inhibition on the viability, ROS generation and mechanical properties of cervical cancer cells.
    Fang Z; Jiang C; Feng Y; Chen R; Lin X; Zhang Z; Han L; Chen X; Li H; Guo Y; Jiang W
    Biochim Biophys Acta; 2016 Sep; 1863(9):2245-54. PubMed ID: 27217331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Transcription Coregulator RIP140 Inhibits Cancer Cell Proliferation by Targeting the Pentose Phosphate Pathway.
    Jacquier V; Gitenay D; Cavaillès V; Teyssier C
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-6-phosphate dehydrogenase and transketolase: Key factors in breast cancer progression and therapy.
    Zhen X; Zhang M; Hao S; Sun J
    Biomed Pharmacother; 2024 Jul; 176():116935. PubMed ID: 38876050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.